Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies.

Dianthus Therapeutics, Inc. is headquartered in New York City. The company is focused on developing complement therapeutics for patients with severe autoimmune and inflammatory diseases. The stock ...